Generation of a TIMP3 knockout stem cell line via CRISPR/Cas9 system

被引：0
|
作者：
Yi, Tong [1 ]
Liu, Jingjing [1 ]
Zhang, Siyao [1 ]
He, Yihua [1 ,2 ]
Han, Jiancheng [1 ,2 ]
机构：
[1] Capital Med Univ, Beijing Anzhen Hosp, Dept Ultrasound, Beijing Key Lab Maternal Fetus Med Fetal Heart Dis, Beijing, Peoples R China
[2] Beijing Anzhen Hosp, Dept Ultrasound, Beijing Key Lab Maternal Fetus Med Fetal Heart Dis, 2 Anzhen Rd, Beijing 100029, Peoples R China
来源：
STEM CELL RESEARCH | 2023年 / 67卷
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1016/j.scr.2023.103034
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
The tissue inhibitors of metalloproteinases 3 (TIMP3) play an essential role in the tumorigenesis of human pancreatic endocrine tumors and Sorsby fundus dystrophy. To further investigate the significance of TIMP3 in disease, we used CRISPR/Cas9 to create a TIMP3 knock out human embryonic stem cell line (WAe009-A-89) that can differentiate into any desired cell type. Our results show that the WAe009-A-89 cell line retains the typical colony form and normal karyotype of stem cells. The cells strongly expressed pluripotency markers and could differentiate into tissues of all three germ layers in vivo. This cell line allowed exploring the role of the TIMP3 gene in related diseases.
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Generation of a COL1A2 homozygous knockout stem cell line via CRISPR/Cas9 system
    Ma, Shuhong
    Saleem, Amina
    Li, Xiaowei
    Lu, Wen-Jing
    Jiang, Hongfeng
    STEM CELL RESEARCH, 2022, 59
  • [2] Generation of a PPP1CA knockout human pluripotent stem cell line via CRISPR/Cas9
    Wang, Xiaoman
    Sun, Jiaan
    Fu, Chong
    Liu, Chang
    STEM CELL RESEARCH, 2023, 69
  • [3] Generation of a homozygous TAZ knockout hESCs line by CRISPR/Cas9 system
    Zhou, Meng
    Huang, Pufeng
    Bai, Rui
    Liu, Xujie
    STEM CELL RESEARCH, 2022, 64
  • [4] Generation of a homozygous RANGRF knockout hiPSC line by CRISPR/Cas9 system
    Jiang, Meiling
    Tang, Chengcheng
    Luo, Xian
    Zhou, Xiaoqing
    Chen, Min
    Chi, Yue
    Lai, Liangxue
    Zou, Qingjian
    STEM CELL RESEARCH, 2023, 71
  • [5] Generation of a FOXH1 homozygous knockout human embryonic stem cell line by CRISPR/Cas9 system
    Zhang, Tian
    Huang, Wanlan
    Xue, Xingkui
    STEM CELL RESEARCH, 2021, 50
  • [6] Generation of a homozygous DNAJC19 knockout human embryonic stem cell line by CRISPR/Cas9 system
    Chen, Guangduo
    Bai, Rui
    Huang, Pufeng
    Liu, Xujie
    Ni, Jie
    Chen, Lianglong
    STEM CELL RESEARCH, 2024, 77
  • [7] Generation of a TBX20-knockout human embryonic stem line by CRISPR/Cas9 system
    Wu, Xiaodan
    Wang, Xiantao
    STEM CELL RESEARCH, 2023, 69
  • [8] Generation of a TSC2 knockout embryonic stem cell line by CRISPR/ Cas9 editing
    Zhang, Siyao
    Fan, Jiaqi
    Sun, Hairui
    Hao, Xiaoyan
    He, Yihua
    STEM CELL RESEARCH, 2024, 77
  • [9] Generation of a DKK2 homozygous knockout human embryonic stem cell line using the CRISPR/Cas9 system
    Zhang, Wang
    Li, Yuming
    Wang, Li
    Xin, Tao
    Zhang, Canwei
    STEM CELL RESEARCH, 2021, 57
  • [10] Generation of LEPR Knockout Rabbits with CRISPR/CAS9 System
    Yu. Yu. Silaeva
    P. D. Safonova
    D. V. Popov
    M. A. Filatov
    Yu. D. Okulova
    R. A. Shafei
    O. I. Skobel
    D. E. Vysotskii
    Yu. D. Gubarev
    V. I. Glazko
    T. T. Glazko
    P. G. Georgiev
    G. Yu. Kosovsky
    M. V. Shepelev
    Doklady Biological Sciences, 2024, 518 (1) : 248 - 255
12345